Research Methods and Statistics
Alessandro De Nadai, Ph.D. (he/him/his)
Assistant Professor
McLean Hospital/Harvard Medical School
Belmont, Massachusetts, United States
Alexander Crenshaw, Ph.D. (he/him/his)
Assistant Professor
Kennesaw State University
Kennesaw, Georgia, United States
Brian Baucom, Ph.D. (he/him/his)
Assistant Professor
University of Utah
salt lake city, Utah, United States
Alessandro De Nadai, Ph.D. (he/him/his)
Assistant Professor
McLean Hospital/Harvard Medical School
Belmont, Massachusetts, United States
Alexander Crenshaw, Ph.D. (he/him/his)
Assistant Professor
Kennesaw State University
Kennesaw, Georgia, United States
Robyn Kilshaw, M.S. (she/her/hers)
University of Utah
Salt Lake City, Utah, United States
Gemma Wallace, Ph.D. (she/her/hers)
Clinical Psychology Resident
Alpert Medical School of Brown University
Providence, Rhode Island, United States
Antonio Morgan-Lopez, Ph.D. (he/him/his)
Fellow
RTI International
Research Triangle Park, North Carolina, United States
Many areas of society are experiencing the impact of advancing technological change and an increase in data-dependence. CBT is also being impacted, because these changes create a need and opportunity for innovative clinical research methods that better match the complexities of mental health research and practice. In line with that need and opportunity, research in clinical psychology has increasingly focused on creative approaches to understanding psychopathology and evaluating treatment outcome. These methods seek to align statistical and methodological tools with the empirical reality of psychology, recognizing that traditional methods may obscure the unique experiences and well-being of individuals. To address these needs, innovative data-driven and individualized approaches provide an opportunity for research and treatment to better match the needs of individuals in their communities. Such approaches can offer novel strategies for identifying those in need of care and help to better understand symptom structures and dependencies, identify the levers for change, evaluate treatment outcomes, and maximize the utility of data. In this symposium, we will present cutting-edge methodological developments for identifying, understanding, and evaluating treatments at the individual and group levels. First, Robyn Kilshaw will discuss current challenges in identifying those in the general community at risk for mental health conditions. Through her presentation, she will cover the newest updates in digital phenotyping and the use of smartphone data to identify underserved individuals in need of care. Following this, Gemma Wallace will highlight recent developments in network analysis as applied to women who have experienced interpersonal violence. Alexander Crenshaw will subsequently concentrate on how to better define group- and individual-level clinical change so that results are maximally comparable across studies. This work can facilitate incremental science that builds upon a single common metric. Antonio-Morgan Lopez will then address how to better define clinically significant change within individual studies by using moderated nonlinear factor analysis and measurement error-corrected multilevel models. Finally, Alessandro De Nadai will conclude the symposium by discussing strategies to increase effect sizes and reduce sample sizes for CBT research by addressing data pollution. Data pollution encompasses frequent but underrecognized errors in data, and potential resolutions are especially relevant when samples do not fully incorporate participants from demographically minoritized groups. Lastly, our discussant Brian Baucom will discuss the collective implications of all of the presentations by drawing on his expertise in quantitative methodologies for clinical science. Together, these presentations showcase state-of-the art methodology that offers novel insights into CBT. They are particularly relevant for improving research and clinical practice with underrepresented patient populations, who may be overlooked by conventional approaches that are less informative and precise.
Speaker: Alessandro S. De Nadai, Ph.D. (he/him/his) – McLean Hospital/Harvard Medical School
Co-author: Ryan Zamora, M.S. (he/him/his) – McLean Hospital/Harvard Medical School
Co-author: Alyse Finch, M.A. (she/her/hers) – McLean Hospital/Harvard Medical School
Speaker: Alexander O. Crenshaw, Ph.D. (he/him/his) – Kennesaw State University
Co-author: Ameesha Narine, BS – Kennesaw State University
Co-author: Mohamed Hashi, MA – Kennesaw State University
Co-author: Kianan Carr – Kennesaw State University
Co-author: Tharun Derangula, B.Tech – Kennesaw State University
Co-author: Yeonkuk Woo, BS – Kennesaw State University
Speaker: Robyn E. Kilshaw, M.S. (she/her/hers) – University of Utah
Co-author: Emma Butner, BS (she/her/hers) – University of Utah
Co-author: Abigail Boggins, BA (she/her/hers) – University of Utah
Co-author: Olivia Everett, BA (she/her/hers) – University of Utah
Co-author: Feea Leifker, M.P.H., Ph.D. (she/her/hers) – University of Utah
Co-author: Brian Baucom, Ph.D. (he/him/his) – University of Utah
Speaker: Gemma T. Wallace, Ph.D. (she/her/hers) – Alpert Medical School of Brown University
Co-author: Gemma T. Wallace, Ph.D. (she/her/hers) – Alpert Medical School of Brown University
Co-author: Leslie Brick, Ph.D. – Alpert Medical School of Brown University
Co-author: Alexa M. Raudales, M.A. – University of Rhode Island
Co-author: Nicole Weiss, Ph.D. – University of Rhode Island
Speaker: Antonio A. Morgan-Lopez, Ph.D. (he/him/his) – RTI International
Co-author: Antonio A. Morgan-Lopez, Ph.D. (he/him/his) – RTI International
Co-author: Lissette Saavedra, PhD – RTI International